New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Bath & Body Works, Inc.

BBWI

Consumer Cyclical Specialty Retail

Bath & Body Works, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $7.3 billion, roughly unchanged from fiscal 2025.

Revenue
−1.07%
EPS
−48.6%
Free cash flow
n/m
Total debt
−13.4%

Quarter to October 2026, against a year earlier

18.91 0.25 +1.34%

After hours trading: 18.91, unchanged, last trade 4:00pm Eastern.

Market cap
$3.8B
P/E
5.2×
Fwd P/E FY27e
7.1×
Dividend yield
4.23%
F-score
6/9
ROIC
37.2%
Net debt / EBITDA
2.1×
Payout ratio
0.2×

Ratios over time Q4 FY26 to Q3 FY27

Returns on capital

ROIC was 37.2% in Q3 FY27, the lowest of these four quarters.

ROEROIC
Q4 FY26Q1 FY27Q2 FY27Q3 FY27
ROE−48.8%−56.3%−60.0%−54.9%
ROIC42.4%43.2%42.7%37.2%

Debt

Net debt is 18.48× a year’s EBITDA.

Net debt / EBITDA
Q4 FY26Q1 FY27Q2 FY27Q3 FY27
Net debt / EBITDA4.4×9.6×10.3×18.5×

Cash cycle, in days

Customers pay in 9 days, inventory is held 116 days and suppliers are paid in 83. Cash is tied up for 42 days between paying for goods and being paid.

Cash cycleDays to pay suppliersDays to be paid
Q4 FY26Q1 FY27Q2 FY27Q3 FY27
Cash cycle30252742
Days to pay suppliers41496183
Days to be paid9589

Per share, from Q4 FY26

Since Q4 FY26, per share: free cash flow has grown 33.6%; revenue has grown 2.1%.

Free cash flowRevenue
Q4 FY26Q1 FY27Q2 FY27Q3 FY27
Free cash flow1.0×1.1×1.2×1.3×
Revenue1.0×1.0×1.0×1.0×
Older periods Jan '26 Apr '26 Jul '26 Oct '26 From the 10-Q filed 19 Nov
Piotroski F-Score

+8 more TTM periods

6 6 6 6
ROE
(48.76%) (56.33%) (60.05%) (54.94%)
ROA
13.06% 14.77% 15.67% 14.73%
ROIC
42.39% 43.17% 42.72% 37.18%
Return on Tangible Assets
41.74% 44.66% 53.90% 53.61%
Average Days of Receivables
9.01 4.94 7.80 8.98
Free Cash Flow per Share
4.20 4.61 5.21 5.61
Free Cash Flow
874.00 926.00 1,048.00 1,128.00
Capital Expenditures
(228.00) (232.00) (225.00) —
Other line items
Cash ROIC
24.51% 28.04% 31.25% 43.79%
Accounts Receivable Turnover
37.88 72.09 50.60 41.58
Accounts Payable Turnover
10.22 8.16 6.48 4.75
Inventory Turnover
5.73 4.98 4.33 3.18
Average Days of Payables
41.38 49.41 61.26 82.94
Days of Inventory on Hand
62.20 69.36 80.01 115.99
Tax Rate
(0.26) (0.19) (0.20) (0.19)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
28.30% 27.36% 27.39% 27.92%
Share Based Compensation of Revenue
0.43% 0.40% 0.32% 0.32%
Interest Coverage
4.08 4.19 4.49 4.46
Operating CF/Net income
1.70 1.59 1.63 1.52
Depreciation/Fixed assets
0.23 0.23 0.22 0.22
Capex/Depreciation
(0.90) (0.92) (0.91) 0.00
Revenue per Share
35.05 36.04 35.87 35.79
Operating CF per Share
5.30 5.76 6.33 5.61
Capex per Share
(1.10) (1.15) (1.12) 0.00
Capex to Sales
0.03 0.03 0.03 0.00

Fold the line items

Columns are period end dates · fundamentals updated 19 Nov 2026